Chimeron Bio receives NIH (NCI) Innovative Concept Award for mRNA cancer vaccine development
read more
https://www.chimeron.com/wp-content/uploads/2024/06/RECIPIENT-Innovative-Concept-Award.png
900
900
Chimeron Bio | Redefining Cancer Therapeutics
Chimeron Bio | Redefining Cancer Therapeutics
https://www.chimeron.com/wp-content/uploads/2024/06/RECIPIENT-Innovative-Concept-Award.png
Harnessing Genetic Medicine & saRNA to Transform Oncology
Developing in vivo CAR, immuno-oncology, and cancer vaccine therapeutics.
Our Mission
We're dedicated to advancing genetic medicine and transforming cancer treatment. Our groundbreaking therapies leverage innovative science to achieve unparalleled gene expression and therapeutic potency, positioning us at the forefront of developing breakthrough enhanced in vivo CAR-T therapies.
We are also pioneering breakthroughs in immuno-oncology and cancer vaccines -- offering new hope in the battle against cancer.
How we do it
Chimeron Bio's unique approach achieves superior expression and broader dynamic range compared to other leading RNA based therapeutics.
In the News
The Latest from Chimeron Bio
Chimeron Bio recognized by MilliporeSigma as a finalist in the Advance Biotech Grant Award
read more
https://www.chimeron.com/wp-content/uploads/2024/06/Chimeron-Finalist-Award-Advance-Biotech-Grant-Award-June-2023.png
750
750
Chimeron Bio | Redefining Cancer Therapeutics
Chimeron Bio | Redefining Cancer Therapeutics
https://www.chimeron.com/wp-content/uploads/2024/06/Chimeron-Finalist-Award-Advance-Biotech-Grant-Award-June-2023.png
Chimeron Bio recognized by MilliporeSigma as a finalist in the Advance Biotech Grant Award
Chimeron Bio Appoints Antonin de Fougerolles to its Board of Directors
read more
https://www.chimeron.com/wp-content/uploads/2023/05/Tony-de-Fougerolles-PhD.png
300
300
Chimeron Bio | Redefining Cancer Therapeutics
Chimeron Bio | Redefining Cancer Therapeutics
https://www.chimeron.com/wp-content/uploads/2023/05/Tony-de-Fougerolles-PhD.png
Chimeron Bio Appoints Antonin de Fougerolles to its Board of Directors
Chimeron Bio Welcomes Kevin Heyeck as New CEO
read more
https://www.chimeron.com/wp-content/uploads/2023/05/MicrosoftTeams-image-78-1.png
300
300
Chimeron Bio | Redefining Cancer Therapeutics
Chimeron Bio | Redefining Cancer Therapeutics
https://www.chimeron.com/wp-content/uploads/2023/05/MicrosoftTeams-image-78-1.png
Chimeron Bio Welcomes Kevin Heyeck as New CEO
Chimeron Bio Enters Into Manufacturing Agreement With FUJIFILM Diosynth Biotechnologies to Advance its RNA Oncology Candidates
read more
https://www.chimeron.com/wp-content/uploads/2023/05/FUJI.webp
206
206
Chimeron Bio | Redefining Cancer Therapeutics
Chimeron Bio | Redefining Cancer Therapeutics
https://www.chimeron.com/wp-content/uploads/2023/05/FUJI.webp